Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects by Meijer, Suzy E., Halutz, Ora, Adler, Amos, Levytskyi, Katya, Tau, Luba, Dekel, Michal, Cohen-Poradosu, Ronit, Katchman, Evgene, Shasha, David, Ablin, Jacob, Choshen, Guy, Jacob, Giris, Wasserman, Asaf, Ingbir, Merav, Cohen, Yael C., Perry, Chava, Ram, Ron, Herishanu, Yair, Bar On, Yael, van Thijn, Elma, Rutsinsky, Natalie, Harari, Sheri, Stern, Adi, Ben-Ami, Ronen, Paran, Yael

Get full text